Emtricitabine is a nucleoside reverse-transcriptase inhibitor used as an active pharmaceutical ingredient in the manufacturing of medications for HIV infection. It is an analog of the nucleoside cytidine and is supplied as a pharmaceutical raw material for formulation development.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 143491-57-0
2-methyl-L-alanyl-N-[(3R,4S,5S)-3-methoxy-1-{(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-{[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino}propyl]pyrrolidin-1-yl}-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide
pharmaceutical raw material
Zidebactam
pharmaceutical raw material
Methoxy Eltrombopag
pharmaceutical raw material
Bis((2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[hydroxy-[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide);(E)-but-2-enedioic acid
pharmaceutical raw material
(+)-emtricitabine
pharmaceutical raw material
Emtricitabine carboxylic acid
pharmaceutical intermediate
Lamivudine
pharmaceutical raw material
1,3-Oxathiolane-2-carboxylic acid, 5-(4-amino-2-oxo-1(2H)-pyrimidinyl)-, (2R,5S)-
pharmaceutical intermediate
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
XQSPYNMVSIKCOC-NTSWFWBYSA-N
C1[C@H](O[C@H](S1)CO)N2C=C(C(=NC2=O)N)F